Reynold A. Panettieri, Jr, M.D.
Vice Chancellor for Translational Medicine and Science Director, Rutgers Institute for Translational Medicine and Science Professor of Medicine, Robert Wood Johnson Medical School Emeritus Professor of Medicine, University of Pennsylvania
Rutgers Institute for Translational Medicine and Science
Child Health Institute of New Jersey
Rutgers, The State University of New Jersey
89 French Street
New Brunswick, NJ 08901
M.D., University of Pennsylvania, Philadelphia, PA
Hospital of the University of Pennsylvania, Philadelphia, PA
Hospital of the University of Pennsylvania, Philadelphia, PA
Reynold A. Panettieri, Jr, MD, the inaugural Director of the Institute for Translational Medicine and Science and Vice Chancellor for Translational Medicine and Science at Rutgers University, previously served as the Director of the Airways Biology Initiative at the University of Pennsylvania. His interests include the cellular and molecular mechanisms that regulate airway smooth muscle cell growth and the immunobiology of airway smooth muscle. Consequences of increases in airway smooth muscle growth promote the development of irreversible airflow obstruction and airway remodeling seen in patients with chronic severe asthma. Dr. Panettieri’s lab also focuses on cytosolic signaling pathways that mediate gene expression and alter myocyte growth.
Dr. Panettieri also served as the Deputy Director of the Center of Excellence in Environmental Toxicology at the University of Pennsylvania. He directed the human exposure chamber that defines the molecular mechanisms regulating ozone- and particulate matter-induced airway hyperresponsiveness.
In addition to his research and clinical interests, Dr. Panettieri served as chairperson of the NIH Lung Cellular, Molecular, and Immunobiology Study Section, is a member of the NIH Distinguished Editorial Panel, and is a member of the American Society for Clinical Investigation and Association of American Physicians.
Current basic research projects open to fellow participation:
- Immunobiology of airway smooth muscle: A major emphasis of our laboratory focuses on the immunobiology of airway smooth muscle (ASM) cells in asthma and chronic obstructive pulmonary disease (COPD). We have characterized that ASM can orchestrate and perpetuate airway inflammation through the secretion of chemokines/cytokines and expression of cell adhesion molecules. We define the critical signaling pathways by which structural cells modulate inflammatory responses, specifically the interplay of nuclear receptors such as vitamin D and glucocorticoids in inhibiting pro-inflammatory signals in mesenchymal cells.
- Airway smooth muscle growth and airway remodeling: In some but not all patients with asthma, irreversible airflow obstruction occurs that evokes morbidity and mortality. A seminal finding of airway remodeling is increases in ASM mass. Our studies have recently defined that Regulators of G protein coupled Signaling (RGS) modulate ASM contractile responses and promote ASM cell growth. Our studies focus on novel approaches to inhibit ASM growth and maintain the contractile nature of human ASM cells. Specific tools utilize molecular approaches for cell signaling, as well as, novel imaging of cytosolic calcium and confocal bronchoscopy.
- Environmental health studies and airway smooth muscle cell function: Ozone and other environmental toxins can induce airway hyperresponsiveness. The molecular mechanisms regulating ozone-mediated airway inflammation and airway hyperresponsiveness remain unclear. Our studies have defined novel eicosanoids and prostaglandins that mediate ozone-induced inflammation. Using translational biologic approaches in which a human exposure chamber delivers ozone to well-characterized patients with asthma and COPD, the characteristics of airway hyperresponsiveness and the molecular mechanisms regulating these phenotypes are defined.
- Novel therapeutic approaches to treat airways diseases: Our laboratory has devoted considerable effort to collaborate with most major pharmaceutical companies to identify novel targets and platforms to test new therapeutic approaches in asthma and COPD. Using precision cut lung slices (PCLS) from humans and mice, the fundamental processes that regulate ASM contraction and growth can be defined, and novel therapeutics to inhibit such processes are characterized.
- Huang J, Lam H, Koziol-White C, Limjunyawong N, Kim D, Kim N, Karmacharya N, Rajkumar P, Firer D, Dalesio NM, Jude J, Kurten RC, Pluznick JL, Deshpande DA, Penn RB, Liggett SB, Panettieri RA, Dong X, An SS. The odorant receptor OR2W3 on airway smooth muscle evokes bronchodilation via a cooperative chemosensory tradeoff between TMEM16A and CFTR. PNAS 2020 Oct 23. Online ahead of print.
- Panettieri RA Jr, Chupp G. TENOR Revisited. J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2254-2255.
- Panettieri RA Jr, Carson J, Horton D, Barrett E, Roy J, Radbel J. Asthma and COVID: What Are the Important Questions? J Allergy Clin Immunol Pract. 2020 Jun 22;S2213-2198(20)30606-1. Epub ahead of print.
- Hashem T, Kammala AK, Thaxton K, Griffin RM, Mullany K, Panettieri RA Jr, Subramanian H, Das R. CD2 Regulates Pathogenesis of Asthma Induced by House Dust Mice Extract. Front Immunol. 2020 May 12.
- Radbel J, Jagpal S, Roy J, Brooks A, Tischfield J, Sheldon M, Bixby C, Witt D, Gennaro ML, Horton DB, Barrett ES, Carson JL, Panettieri RA Jr, Blaser MJ. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium. Version 2. J Mol Diagn. 2020 Jul;22(7):871-875. Epub 2020 May 13.
- Moore WC, Panettieri RA Jr, Trevor J, Ledford DK, Lugogo N, Soong W, Chipps BE, Carr W, Belton L, Gandhi H, Trudo F, Ambrose CS. Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma. Ann Allergy Asthma Immunol. 2020 Apr 15;S1081-1206(20)30232-5. Epub ahead of print.
- Omary MB, Eswaraka J, Kimball SD, Moghe PV, Panettieri RA Jr, Scotto KW. The COVID-19 pandemic and research shutdown: staying safe and productive. J Clin Invest. 2020 Jun 1;130(6):2745-2748.
- Wong GS, Redes JL, Balenga N, McCullough M, Fuentes N, Gokhale A, Koziol-White C, Jude JA, Madigan LA, Chan EC, Jester WH, Biardel S, Flamand N, Panettieri RA Jr, Druey KM. RGS4 promotes allergen- and aspirin-associated airway hyperresponsiveness by inhibiting PGE2 biosynthesis. J Allergy Clin Immunol. 2020 Mar 19;S0091-6749(20)30372-9. Epub ahead of print.
- Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ; SOLANA Study Investigators. Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA). J Asthma Allergy. 2020 Feb 17;13:115-126. Erratum in: J Asthma Allergy. 2020 Mar 13.
- Guerrini V, Panettieri RA Jr, Gennaro ML. Lipid-laden macrophages as biomarkers of vaping-associated lung injury. Lancet Respir Med. 2020 Feb;8(2):e6.
- Nuñez FJ, Johnstone TB, Corpuz ML, Kazarian AG, Mohajer NN, Tliba O, Panettieri RA Jr, Koziol-White C, Roosan MR, Ostrom RS. Glucocorticoids rapidly activate cAMP production via G<sub>αs</sub> to initiate non-genomic signaling that contributes to one-third of their canonical genomic effects. FASEB J. 2020 Feb;34(2):2882-2895. Epub 2019 Dec 27.
- Koziol-White C, Johnstone TB, Corpuz ML, Cao G, Orfanos S, Parikh V, Deeney B, Tliba O, Ostrom RS, Dainty I, Panettieri RA Jr. Budesonide enhances agonist-induced bronchodilation in human small airways by increasing cAMP production in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2020 Feb 1;318(2):L345-L355. Epub 2019 Nov 20.
- Pan S, Shah SD, Panettieri RA Jr, Deshpande DA. Bnip3 regulates airway smooth muscle cell focal adhesion and proliferation. Am J Physiol Lung Cell Mol Physiol. 2019 Dec 1;317(6):L758-L767. Epub 2019 Sep 11.
- Koziol-White CJ, Ghosh A, Sandner P, Erzurum SE, Stuehr DJ, Panettieri RA Jr. Soluble Guanylate Cyclase Agonists Induce Bronchodilation in Human Small Airways. Am J Respir Cell Mol Biol. 2020 Jan;62(1):43-48.
- S. Xu, A. Schwab, N. Karmacharya, G. Cao, Panettieri RA Jr., J. Jude; Free Fatty Acid Receptor 1/4 (FFAR1/4) Agonists, GW9508 and TAK875, Attenuate Cell Shortening as Broncho-Protectors in Human Airway Smooth Muscle (HASM) Cells. Rutgers Institute for Translational Medicine & Science, New Brunswick, NJ, United States.
- C.J. Koziol-White, V. Parikh, G.L. Chupp, Panettieri RA Jr.; Blocking YKL-40 (Chitinase-Like Protein Chitinase 3) Reverses IL-13/IL-4-Induced Hyporesponsiveness to Bronchodilators in Human Small Airways and in Human Airway Smooth Muscle Cells Rutgers University, New Brunswick, NJ, United States, Pulmonary Medicine, Yales Univ Sch of Med, New Haven, CT, United States, Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ, United States.
- N. Karmacharya1, S. Chengalvala2, A. Lou2, G. Cao2, W. Jester2, Panettieri RA Jr., J. Jude2; Cholecystokinin Evokes Excitation-Contraction Coupling in Human Airway Smooth Muscle Cells Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ, United States, 2Institute for Translational Medicine and Science, Rutgers University, NEW BRUNSWICK, NJ, United States
- N. Karmacharya1, S. Chengalvala2, N. Sadekar3, W. Jester2, Panettieri RA Jr., J. Jude2; Dermal Sensitizer 1-Chloro-2,4-Dinitrobenzene (DNCB) Induces TSLP Expression in Precision-Cut Human Lung Slices Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ, United States, 2Institute for Translational Medicine and Science, Rutgers University, NEW BRUNSWICK, NJ, United States, 3Research Institute for Fragrance Materials, Woodcliff Lake, NJ, United States.
- Barrett ES, Horton DB, Roy J, Xia W, Greenberg P, Andrews T, Gennaro ML, Parmar V, Russell WD, Reilly N, Uprety P, Gantner JJ, Stockman L, Trooskin SZ, Blaser MJ, Carson JL, Panettieri RA Jr.Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospital Workers: Results From a Screening Study in New Jersey, United States in Spring 2020 Open Forum Infect Dis. 2020 Oct 31;7(12):ofaa534. doi: 10.1093/ofid/ofaa534. PMID: 33403219; PMCID: PMC7665723.
- Barrett ES, Horton DB, Roy J, Gennaro ML, Brooks A, J, Greenberg P, Andrews T, Jagpal S, Reilly N, Blaser MJ, Carson JL, Panettieri RA Jr. Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemic medRxiv [Preprint]. 2020 Apr 24:2020.04.20.20072470. : 10.1101/2020.04.20.20072470. Update in: BMC Infect Dis. 2020 Nov 16;20(1):853. PMID: 32511600; PMCID: PMC7276027.